Fundamental company data provided by Zacks Investment Research. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Akers Biosciences employs 12 workers across the globe. The company traded as low as $2.76 and last traded at $2.78. Thomas A. Nicolette has an approval rating of 64% among Akers Biosciences' employees. Akers Biosciences, Inc focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. Coty Stock Providing Pullback Opportunities, America’s Car-Mart (NASDAQ:CRMT) Sets New High As Business Accelerates, 6 Hot Cannabis Stocks For Penny Stock Investors, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission, Akers Biosciences Responds to Erroneous Earnings Call Press Release, AKERS ALERT: Bragar Eagel & Squire, P.C. Akers Biosciences' mailing address is 201 GROVE RD, THOROFARE NJ, 08086. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers, SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKER, REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals, AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER. All rights reserved. Learn about financial terms, types of investments, trading strategies and more. Akers Biosciences is headquartered at 201 GROVE RD, THOROFARE NJ, 08086. The medical instruments supplier had revenue of $0.56 million for the quarter. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Top institutional investors include NorthRock Partners LLC (4.80%). If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…, CEO, Principal Exec. Learn everything you need to know about successful options trading with this three-part video course. Since then, AKER stock has increased by 57.5% and is now trading at $3.56. The high price target for ANIX is $8.50 and the low price target for ANIX is $8.50. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Shares of AKER can be purchased through any online brokerage account. RM LAW Announces Investigation of Akers Biosciences, Inc. View Akers Biosciences' earnings history. MarketBeat's community ratings are surveys of what our community members think about Akers Biosciences and other stocks. Looking for new stock ideas? Compare Top Brokerages Here. Since then, AKER stock has increased by 77.9% and is now trading at $4.02. The business’s 50-day moving average is $2.27 and its 200-day moving average is $2.88. Analyst Opinion on Anixa Biosciences (NASDAQ:ANIX) 1 Wall Street analysts have issued ratings and price targets for Anixa Biosciences in the last 12 months. Arista Gets Back to Growth, Should You Buy? Do Not Sell My Information. © American Consumer News, LLC dba MarketBeat® 2010-2021. Akers Biosciences trades on the NASDAQ under the ticker symbol "AKER.". ExxonMobil and IBM's researchers have been working together to find quantum algorithms that could manage the global fleet of merchant ships. The company traded as low as $2.76 and last traded at $2.78. Akers Biosciences' stock was trading at $2.26 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Their average twelve-month price target is $34.25, predicting that the stock has a possible upside of 85.34%. Akers Biosciences has received 57.71% “outperform” votes from our community. Teachable moments from GameStop, Deere & Company (NYSE:DE) Turns In Huge Earnings Beat, Jack In The Box Stock Is Ready To Spring Forward. The business’s 50-day moving average […] View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. It has a collaboration agreement with Premas Biotech PVT Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. AKER stock was acquired by a variety of institutional investors in the last quarter, including NorthRock Partners LLC. Akers Biosciences' stock was trading at $2.26 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Only 5.52% of the stock of Akers Biosciences is held by institutions. Identify stocks that meet your criteria using seven unique stock screeners. The stock had previously closed at $3.06. Officer, Pres & Director, Start Your Risk-Free Trial Subscription Here, Perion Networks Stock Has More Upside From Here, Closing prices for crude oil, gold and other commodities, UK top court gives Uber drivers benefits in landmark ruling, Water leaks indicate new damage at Fukushima nuclear plant, Massive breach fuels calls for US action on cybersecurity, 'Mom, can I buy stocks?' The stock had previously closed at $3.06. Akers Biosciences, Inc. (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company. Akers Biosciences, Inc. (NASDAQ:AKER) dropped 9.2% during mid-day trading on Wednesday . The medical instruments supplier reported ($0.26) EPS for the quarter. Akers Biosciences has received 307 “outperform” votes. Get short term trading ideas from the MarketBeat Idea Engine. Akers Biosciences, Inc. (NASDAQ:AKER) dropped 9.2% during mid-day trading on Wednesday . One share of AKER stock can currently be purchased for approximately $3.56. Use the search box above to search for a stock, or use CTRL+F or CMD+F on your keyboard to look through the list below. Some companies that are related to Akers Biosciences include ImmuCell (ICCC), Biomerica (BMRA), Navidea Biopharmaceuticals (NAVB), StageZero Life Sciences (GNWSF), StageZero Life Sciences (GNWSD), Achieve Life Sciences (ACHV), ARCA biopharma (ABIO), BG Medicine (BGMD), Response Genetics (RGDXQ), FluoroPharma Medical (FPMI), Fuse Science (DROP) and Hemagen Diagnostics (HMGN). Learn more. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Litigated stockholder derivative action and post-merger claims. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The high price target for DYN is $47.00 and the low price target for DYN is $27.00. See what's happening in the market right now with MarketBeat's real-time news feed. View which stocks are hot on social media with MarketBeat's trending stocks report. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View our earnings forecast for Akers Biosciences. Based on aggregate information from My MarketBeat watchlists, some companies that other Akers Biosciences investors own include ImmunoGen (IMGN), Sorrento Therapeutics (SRNE), AVEO Pharmaceuticals (AVEO), Advanced Micro Devices (AMD), Aytu BioScience (AYTU), Biopharmx (BPMX), Neovasc (NVCN), Micron Technology (MU), Vaxart (VXRT) and Anavex Life Sciences (AVXL). Investigates Sale of AKER and Encourages Investors to Contact the Firm, Rapid Tests Market Analysis Report contains all study material about Market Overview, Growth, Demand and Forecast Research with Top Countries Data, Global Rapid Tests Market Share - 2021, Size, Growth & value, Competitive Situation and Trends, Business Revenues, Opportunities and Drivers 2027, Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent, SHAREHOLDER ALERT: Rigrodsky & Long, P.A. The post Don’t Get Distracted by Nokia’s ‘Meme Stock’ Status appeared first on InvestorPlace. The company was founded in 1989 and is headquartered in Thorofare, New Jersey. To see all exchange delays and terms of use please see disclaimer. The medical instruments supplier can be reached via phone at 856-848-8698 or via email at [email protected]. View insider buying and selling activity for Akers Biosciences or or view top insider-buying stocks. Sign-up to receive the latest news and ratings for AKER and its competitors with MarketBeat's FREE daily newsletter. Receive News & Ratings for Akers Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences and related companies with MarketBeat.com's FREE daily email newsletter. MarketBeat just released five new trading ideas, but Akers Biosciences wasn't one of them. Receive Analysts' Upgrades and Downgrades Daily. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. The medical instruments supplier reported ($0.38) earnings per share (EPS) for the quarter. There is not enough analysis data for Akers Biosciences. In the past three months, Akers Biosciences insiders have not sold or bought any company stock. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Seneca Foods's (NASDAQ:SENEA) stock is trading up 12.19% to a price of $42.5. Posted by Hayley Millar on Jan 28th, 2021. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. This includes stock price, detailed quote, interactive chart, key metrics, and financials. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The official website for Akers Biosciences is www.akersbio.com. Mesirov v. Enbridge Energy Co., Inc. Receive a free world-class investing education from MarketBeat. Akers Biosciences does not have a long track record of dividend growth. View which stocks have been most impacted by … View which stocks have been most impacted by COVID-19. Akers Biosciences' management team includes the following people: Tech Stocks to drop 92%??